NCT02378805View on ClinicalTrials.gov

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

July 31, 1995

Primary Completion Date

March 1, 2036

Study Completion Date

March 1, 2036

Conditions
Alport SyndromeHereditary Kidney DiseasePediatric Kidney DiseaseThin Basement Membrane DiseaseFamilial Benign Hematuria
Interventions
DRUG

ACE-inhibitor

observational study

DRUG

Angiotensin-receptor blocker (ARB)

observational study

DRUG

HMG-Coenzyme inhibitor (statin)

observational study

DRUG

Spironolactone or Finerenone

observational study

DRUG

Paricalcitol

observational study!

DRUG

SGLT2 inhibitor

observational study

Trial Locations (1)

37075

RECRUITING

University Medical Center Göttingen, Göttingen

All Listed Sponsors
collaborator

Society for Pediatric Nephrology (Germany)

OTHER

lead

University Hospital Goettingen

OTHER